Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.

Saved in:
Bibliographic Details
Title: Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
Authors: Kelley RK; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Joseph NM; Department of Pathology, University of California, San Francisco (UCSF), San Francisco, California, USA., Nimeiri HS; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Hwang J; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Kulik LM; Division of Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois, USA., Ngo Z; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Behr SC; Department of Radiology, University of California, San Francisco (UCSF), San Francisco, California, USA., Onodera C; Clinical Cancer Genomics Lab, UCSF Health, San Francisco, California, USA., Zhang K; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Bocobo AG; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Benson AB; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Venook AP; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Gordan JD; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.
Source: Liver cancer [Liver Cancer] 2021 Sep 06; Vol. 10 (6), pp. 561-571. Date of Electronic Publication: 2021 Sep 06 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: eCollection Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2235-1795
DOI:10.1159/000518297